The Science of Scale: De-Risking Innovation in the Wellness Industry

SPRINGVILLE, UT – June 11, 2026 – In the booming health and wellness industry, a promising idea is only the first step on a perilous journey to the consumer's shelf. The path is littered with concepts that were scientifically compelling but failed in execution—products that tasted unpleasant, separated in the bottle, or simply couldn't be manufactured consistently at scale. This gap between clinical science and commercial reality represents a multi-billion dollar risk for brands. Now, a Utah-based contract development and manufacturing organization (CDMO) is tackling this problem head-on with a new model that puts deep scientific expertise at the very beginning of the product lifecycle.

Innovative Labs, a company with nearly two decades of experience, has launched a fully integrated Innovation Center designed to de-risk and accelerate product development. By embedding PhD-level nutritional scientists into the process from day one, the company aims to ensure that a product is not just innovative, but also stable, palatable, and scalable before significant investment is made.

The Billion-Dollar Formulation Gap

The market opportunity is undeniable. The global nutraceutical CDMO market was valued at nearly $40 billion in 2026, with projections showing sustained, aggressive growth. This expansion is fueled by a consumer base increasingly focused on preventative health, demanding sophisticated products that deliver tangible benefits. Yet, as product complexity grows, so does the risk of failure.

Liquid supplements, a market projected to exceed $41 billion by 2034, are a prime example of this challenge. While offering advantages in bioavailability and consumer convenience, they present a minefield of formulation hurdles. "You're dealing with a complex chemical soup," notes a product development consultant not affiliated with the company. "Active ingredients, botanicals, proteins, and minerals all have different pH sensitivities, solubility profiles, and oxidation rates. Getting them to coexist happily in a liquid suspension without turning into sediment or developing off-notes over a 12-month shelf life is a significant scientific achievement."

This is where many brands falter. A formula that works perfectly in a small lab beaker can behave unpredictably in a 1,000-gallon manufacturing tank. These late-stage failures are not just costly; they can derail a product launch, damage a brand's reputation, and waste months of development time. The industry has long needed a more predictive and integrated development model.

A Science-First Approach to Commercialization

The new Innovation Center at Innovative Labs is structured to be that model. Its leadership team is a clear signal of its strategy. The center is headed by Dr. Steve Wood, a Ph.D. nutritional scientist and registered dietitian with decades of experience in clinical research and product development at major corporations like Abbott Laboratories and Nu Skin. His extensive background, which includes 22 peer-reviewed papers and several patents, brings a level of scientific rigor not always present in the early stages of commercial product development.

"At Innovative Labs, we transform nutrition science into market-ready products," said Dr. Wood, Senior Director of Innovation. "Our Innovation Center unites ingredient science, formulation, sensory excellence, stability, and scalable manufacturing to accelerate product development from concept to commercialization."

The core of their approach is a disciplined, front-loaded evaluation process. Before a formula ever reaches the bench, Dr. Wood and his team, including nutritional science and commercialization expert Jolene Young, M.S., scrutinize the concept for scientific plausibility, ingredient safety, and genuine consumer fit. This initial gatekeeping prevents brands from pursuing concepts that are scientifically unsound or destined for manufacturing failure, saving them from what can become expensive missteps. It’s a shift from a reactive, trial-and-error process to a proactive, science-led strategy.

From Benchtop to Bottling Line, Seamlessly

One of the most significant points of friction in the CDMO world is the handoff between separate R&D, pilot, and manufacturing teams. A formula developed in isolation by one group may not be scalable by another. Innovative Labs' center was built to eliminate this friction by creating a single, integrated team that shepherds a product from initial concept through full-scale production.

This seamless integration provides a crucial advantage. The team has direct access to the company's analytical labs and full-scale manufacturing facilities at every step, allowing them to anticipate and solve production challenges in real-time. A recent project illustrates the power of this methodology: the development of a complex multi-active liquid nutritional product. The formula involved ingredients with conflicting properties that threatened to compromise the product's stability and shelf life. Through iterative testing and meticulous system design within their integrated framework, the team resolved each chemical conflict, delivering a final formula that performs consistently in high-volume production, not just on paper.

This vertically integrated expertise is the practical application of the center's scientific foundation. It ensures that the final product is not only effective and safe but also commercially viable, meeting targets for cost, taste, and stability that are essential for market success.

Navigating a Competitive and Complex Market

Innovative Labs is not the only CDMO serving the burgeoning wellness market; the space includes major players like Vitaquest and Aegle Nutrition, who also offer liquid and powder manufacturing. However, the Utah firm is carving out a distinct niche by branding its expertise and process. The focus on PhD-led, front-loaded scientific validation for complex formulations is a powerful differentiator in a field where speed-to-market can sometimes overshadow scientific due diligence.

By solving the industry's toughest formulation puzzles, particularly in the challenging liquid format, the company is positioning itself as a strategic partner rather than just a contract manufacturer. The approach is about mitigating risk and providing certainty—a valuable proposition for both established brands and startups looking to launch breakthrough products.

Looking ahead, the Innovation Center is already expanding its capabilities into powder formats and personal care products, tapping into adjacent high-growth markets. This move indicates a broader strategy to apply its science-first, integrated model across multiple product categories. By bridging the critical gap between a great idea and a successful product, Innovative Labs is not just building a competitive advantage for itself; it is creating a more reliable pathway for innovation across the entire wellness industry.